ММВБ 3 003 -3,3%  Nasdaq 8 966 -2,8%  Биткойн 9 138 -2,0%  USD/RUB 65,3063 0,0% 
РТС 1 446 -5,2%  S&P500 3 128 -3,0%  Нефть 55,2 0,7%  EUR/RUB 70,9685 -0,1% 
Dow 27 081 -3,2%  FTSE100 7 018 -1,9%  EUR/USD 1,0870 -0,1% 

Курс акций Xencor [ISIN: US98401F1057]

купить
продать

Xencor Inc - Профиль

Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

Акционеры

Название Доля (%)
Freefloat99,04
Fidelity Management & Research Co. LLC14,67
PRIMECAP Management Co.12,33
Ronin Capital LLC11,18
BlackRock Fund Advisors10,20
T. Rowe Price Associates, Inc. (Investment Management)10,01
Vanguard Group, Inc. (Subfiler)9,04
Primecap Odyssey Aggressive Growth Fund8,72
The Vanguard Group, Inc.7,46
Ishares Core S&p Small Cap Etf5,33
Ecor1 Capital LLC4,41
State Street Corp.3,81
Millennium Management LLC2,93
BlackRock Institutional Trust Co. NA2,65
Vanguard Total Stock Market Index Fund2,54

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент